🇺🇸 Prednisolone acetate eye drops in United States

15 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 15

Most-reported reactions

1. Dizziness — 2 reports (13.33%)
2. Drug Hypersensitivity — 2 reports (13.33%)
3. Pain — 2 reports (13.33%)
4. Pneumonia — 2 reports (13.33%)
5. Vision Blurred — 2 reports (13.33%)
6. Abdominal Injury — 1 report (6.67%)
7. Activities Of Daily Living Impaired — 1 report (6.67%)
8. Amnesia — 1 report (6.67%)
9. Anaemia — 1 report (6.67%)
10. Anticoagulation Drug Level Below Therapeutic — 1 report (6.67%)

Source database →

Frequently asked questions

Is Prednisolone acetate eye drops approved in United States?

Prednisolone acetate eye drops does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Prednisolone acetate eye drops in United States?

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.